Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

27. Dezember 2025

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 2930


	Artikel 1 - 20 / 58585

	Advancement in preclinical development of cancer treatment agents through modulation of Rac1: From EHop-016 to natural products. Biochim Biophys Acta Rev Cancer Liu Y, Wong SN, Lyu A, Ko JK. PMID: 41453624 [PubMed - as supplied by publisher]
	The Emerging Triad in Cancer and Aging: Cellular Senescence, Microbiome, and Tumor Microenvironment. Aging Dis Gong X, Wang S, Xia Q. PMID: 41452713 [PubMed - as supplied by publisher]
	"Exosomal blueprint of lung-tropic metastasis: molecular signatures, microenvironmental conditioning, and translational implications in cancer". Med Oncol Ebrahim NAA, Farghaly TA, Soliman SMA. PMID: 41452573 [PubMed - indexed for MEDLINE]
	Ethical challenges and governance of artificial intelligence in hepatocellular carcinoma management : Wan DL et al. Ethical considerations in AI for hepatocellular carcinoma. Med Oncol Wan DL, Lin SZ. PMID: 41452505 [PubMed - indexed for MEDLINE]
	The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer - Authors' reply. Lancet Oncol Janssen QP, van Dam JL, Besselink MG, Wilmink JW, Homs MYV, van Tienhoven G, van Eijck CHJ, Groot Koerkamp B. PMID: 41449160 [PubMed - in process]
	The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer. Lancet Oncol Sherry AD, Jethwa KR, Msaouel P, Ludmir EB. PMID: 41449158 [PubMed - in process]
	The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer. Lancet Oncol Neoptolemos JP, Springfeld C, Öhlund D, Büchler MW, Michalski CW. PMID: 41449156 [PubMed - in process]
	First-line tiragolumab plus atezolizumab and chemotherapy in patients with previously untreated, locally advanced unresectable or metastatic oesophageal cancer (MORPHEUS-EC): a randomised, open-label, phase 1b/2 trial. Lancet Oncol Sun JM, Chao Y, Kim SB, Rha SY, Evans TRJ, Strickland AH, Wainberg Z, Chau I, Pelles-Avraham S, Ajani J, Malhotra R, Liu Q, Li S, Cha E, Kalaitzidou M, Huang X, Allen S, Hsu CH. PMID: 41449151 [PubMed - indexed for MEDLINE]
	A Phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling. Cancer Lett Horvat NK, Diab M, Phillips MJ, Veal-McCook A, Grundy EE, Alese OB, Greene E, Gbolahan O, Coleman K, Doxie D, Herting CJ, Hammons J, Mahdi Z, Switchenko JM, Paulos CM, El-Rayes BF, Lesinski GB. PMID: 41448449 [PubMed - as supplied by publisher]
	From Diagnosis and Treatment to Prognosis: Clinical Prospects of Artificial Intelligence in Multimodal Research of Hepatocellular Carcinoma. Crit Rev Oncol Hematol Jia W, Duan X, Yao Q, Liu R, Cheng CL. PMID: 41448299 [PubMed - as supplied by publisher]
	Transcatheter Arterial Chemoembolization May Be Selectively Indicated as Postoperative Adjuvant Therapy for Hepatocellular Carcinoma Patients with Microvascular Invasion. J Hepatocell Carcinoma Zeng J, Huang H, Tang M, Tao Z, Mo K, Chen W, Su Y, Su J, Liang R, Lin Y, Li L, Wu G, Luo X, Ye J, Mai R. PMID: 41446352 [PubMed]
	Organ-specific role of neutrophil extracellular traps in shaping the postoperative thrombo-inflammatory niche in pancreatic ductal adenocarcinoma: a multi-model machine learning and mechanistic study. Front Immunol Cui S, Wang D, Lyu S, Huang J, Lang R, Wang J. PMID: 41445740 [PubMed - indexed for MEDLINE]
	Integrated transcriptome study reveals a stress response state CD4â€‰+T cells related to immune tolerance in breast cancer. Breast Cancer Res Gu J, Qi Q, Mao X, Cong R, Sun Y, Tang X, Guan X, Wang J, Yu M, Wang S, Pan H, Zhang K, Qiu W, Li W, Wang C, Zhou W. PMID: 41444999 [PubMed - as supplied by publisher]
	Cytotoxic and senescence-inducing effects of BLU554 in pancreatic ductal adenocarcinoma: an in vitro study. BMC Cancer Fujiwara M, Shinji S, Shichi Y, Nonaka K, Hasegawa Y, Takahashi K, Rokutan H, Arai T, Ishiwata T. PMID: 41444543 [PubMed - indexed for MEDLINE]
	Optimized federated learning framework with RegNetZ and Swin-Transformer for multimodal pancreatic cancer detection1. Sci Rep Ge W, Govindarajan V, Yang J, Ayadi M, Shaikh ZA, Li L, Por LY, Liu N, Tu Y. PMID: 41444372 [PubMed - as supplied by publisher]
	Quality of death in cancer: no treatment versus late chemotherapy in a nationwide mortality follow-back study. BMJ Support Palliat Care Nakazawa Y, Hamano J, Miyashita M, Morita T, Kizawa Y, Okumura Y, Kawagoe S, Yamamoto H, Takeuchi E, Yamazaki R, Ogawa A. PMID: 41443950 [PubMed - as supplied by publisher]
	Stromal QSOX1 loss is a distinctive feature of colorectal cancer and correlates with tumor expansion. Histochem Cell Biol Michalichyn ÂC, Bonilha HC, de Noronha L, Saad CT, Muzzi JCD, Eble JA, Zanata SM, Marconi C, Nakao LS. PMID: 41441973 [PubMed - indexed for MEDLINE]
	Important Role of Bacterial Metabolites in Development and Adjuvant Therapy for Hepatocellular Carcinoma. Curr Oncol Ye G, Zhang H, Feng Q, Xiao J, Wang J, Liu J. PMID: 41440201 [PubMed - indexed for MEDLINE]
	Cancer stem cells in hepatocellular carcinoma: therapy resistance and emerging treatments. Front Immunol Yadav DK, Yadav RK, Singh A, Huang Y, Bao D, Yang Z, Huang H, Jiang Y, Wang P, Lin S, Hua Y, Hu Y. PMID: 41438763 [PubMed - indexed for MEDLINE]
	Machine learning-optimized metabolic biomarker panel for precision screening of early-stage pancreatic cancer in new-onset diabetes. Front Endocrinol (Lausanne) Jiang W, Cheng Z, Mu R, Sun H, Guo Z, Yu G, Wang D, Yang L. PMID: 41438299 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 58585

Seite 1 von 2930



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung